November 22, 2024

J&J’s Carvykti approved in Canada for second-line myeloma treatment – World Pharmaceutical Frontiers

November 21, 2024

Multiple Myeloma Experts Face Off on Sequencing Therapy Options – Cancer Network

November 20, 2024

Expanded Indications for CAR T-Cell Therapies Shepard in New Era of Myeloma Care – OncLive

November 20, 2024

Cell surface marker heterogeneity in human myeloma cell lines for modeling of disease and therapy – Nature.com

November 18, 2024

MRD Takes Center Stage: Accelerating Drug Approvals for Multiple Myeloma – Fierce Biotech